Examiner: ULLMAN, AARON RAFANAN

Tech Center 1600 • Art Units: 1628

This examiner grants 0% of resolved cases

Performance Statistics

Allow Rate

-60.0% vs TC avg

Total Applications

Interview Lift

1175

Avg Prosecution Days

Based on 0 resolved cases, 2023–2026

8.3%

§101 Eligibility

16.7%

§102 Novelty

41.7%

§103 Obviousness

33.3%

§112 Clarity

App #	Title	Status	Assignee
18501323	COMBINATIONS FOR TREATMENT OF CANCERS RESISTANT TO EGFR-TARGETED THERAPIES	Non-Final OA	Ohio State Innovation Foundation
18508992	TRAZODONE ORAL SOLUTION	Non-Final OA	OWP Pharmaceuticals, Inc.
18041682	POLYMORPHS OF 5-BROMO-6-CHLORO-3-INDOXYL CAPRYLATE	Non-Final OA	Biosynth AG

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.